CRL Stock Analysis: Buy, Sell, or Hold?
CRL - Charles River Laboratories International, Inc.
$185.00
2.66 (1.46%)
▲
5d:
-1.63%
30d:
+21.37%
90d:
+20.88%
BUY
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When CRL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CRL shows positive signals but monitor for confirmation. Market pricing in 1.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CRL shows positive signals but monitor for confirmation. Market pricing in 1.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$273.55
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$169.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CRL is currently trading at $185.00, which is considered slightly high relative to its 30-day fair value range of $160.31 to $187.96. The stock's valuation (Forward PE: 15.0) is in line with its historical norms (15.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CRL is showing sideways momentum. The price is currently testing key support at $180.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $212.27 (+14.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRL is showing sideways momentum. The price is currently testing key support at $180.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $212.27 (+14.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$160.31 -
$187.96
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($212.27)
Trading Range Analysis
30-Day Trading Range
$160.31 -
$187.96
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$180.55
Resistance Level
$193.81
Current Trend
Sideways
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.03
Wall Street Target
$212.27
(+14.7%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
-17.3%
Profit Margin
-4.6%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
15.0 vs 15.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$182.96
(-1%)
2-Year Target
$180.95
(-2%)
3-Year Target
$178.96
(-3%)
3-Yr Target (if PE normalizes)
(PE: 15→16)
$184.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.0%)
$366.42
(+98%)
Base:
(SPY PE: 15.0, Growth: 11.0%)
$252.84
(+37%)
Bear:
(PE: 12.8, Growth: 11.0%)
$214.92
(+16%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.0 to 15.5
Stabilization Target:
$190.80
(+3.1%)
PE Expansion Potential:
+3.1%
Share & Embed Analysis
Last updated: June 22, 2026 7:58 AM ET
Data refreshes hourly during market hours. Next update: 8:58 AM
Data refreshes hourly during market hours. Next update: 8:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-02-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 59 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 53 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 64 BUY |
